title: Protein kinase C bidirectionally modulates Ih and hyperpolarization-activated cyclic nucleotide-gated (HCN) channel surface expression in hippocampal pyramidal neurons.
abstract: CONCLUSIONS
  Hyperpolarization-activated cyclic nucleotide-gated (HCN) channels, particularly that of the HCN1 isoform, are enriched in the distal dendrites of hippocampal CA1 pyramidal neurons; these channels have physiological functions with respect to decreasing neuronal excitability. In the present study, we aimed to investigate phosphorylation as a mechanism controlling Ih amplitude and HCN1 surface expression in hippocampal principal neurons under normal physiological conditions. Tyrosine phosphorylation decreased Ih amplitude at maximal activation (maximal Ih ), without altering HCN1 surface expression, in two classes of hippocampal principal neurons. Inhibition of serine/threonine protein phosphatases 1 and 2A decreased maximal Ih and HCN1 surface expression in hippocampal principal neurons. Protein kinase C (PKC) activation irreversibly diminished Ih and HCN1 surface expression, whereas PKC inhibition augmented Ih and HCN1 surface expression. PKC activation increased HCN1 channel phosphorylation. These results demonstrate the novel finding of a phosphorylation mechanism, dependent on PKC activity, which bidirectionally modulates Ih amplitude and HCN1channel surface expression in hippocampal principal neurons under normal physiological conditions.
  Hyperpolarization-activated, cyclic nucleotide-gated (HCN) ion channels attenuate excitability in hippocampal pyramidal neurons. Loss of HCN channel-mediated current (Ih ), particularly that mediated by the HCN1 isoform, occurs with the development of epilepsy. Previously, we showed that, following pilocarpine-induced status epilepticus, there are two independent changes in HCN function in dendrites: decreased Ih amplitude associated with a loss of HCN1 surface expression and a hyperpolarizing shift in voltage-dependence of activation (gating). The hyperpolarizing shift in gating was attributed to decreased phosphorylation as a result of a loss of p38 mitogen-activated protein kinase activity and increased calcineurin activity; however, the mechanisms controlling Ih amplitude and HCN1 surface expression under epileptic or normal physiological conditions are poorly understood. We aimed to investigate phosphorylation as a mechanism regulating Ih amplitude and HCN1 surface expression (i.e. as is the case for HCN gating) in hippocampal principal neurons under normal physiological conditions. We discovered that inhibition of either tyrosine phosphatases or the serine/threonine protein phosphatases 1 and 2A decreased Ih at maximal activation in hippocampal CA1 pyramidal dendrites and pyramidal-like principal neuron somata from naïve rats. Furthermore, we found that inhibition of PP1/PP2A decreased HCN1 surface expression, whereas tyrosine phosphatase inhibition did not. Protein kinase C (PKC) activation reduced Ih amplitude and HCN1 surface expression, whereas PKC inhibition produced the opposite effect. Inhibition of protein phosphatases 1 and 2A and activation of PKC increased the serine phosphorylation state of the HCN1 protein. The effect of PKC activation on Ih was irreversible. These results indicate that PKC bidirectionally modulates Ih amplitude and HCN1 surface expression in hippocampal principal neurons.
authors.affiliation: Department of Physiology and Biophysics, University of Washington.
authors.forename: Aaron D
authors.initials: AD
authors.lastname: Williams
authors.affiliation: Department of Physiology and Biophysics, University of Washington.
authors.forename: Sangwook
authors.initials: S
authors.lastname: Jung
authors.affiliation: Department of Physiology and Biophysics, University of Washington.|Department of Neurology and Regional Epilepsy Center, University of Washington, Seattle, WA, USA.
authors.forename: Nicholas P
authors.initials: NP
authors.lastname: Poolos
mesh_terms: D000200:Action Potentials; D000818:Animals; D056547:CA1 Region, Hippocampal / Q000166:cytology / Q000378:metabolism* / Q000502:physiology; D002462:Cell Membrane / Q000378:metabolism; D064428:Hyperpolarization-Activated Cyclic Nucleotide-Gated Channels / Q000378:metabolism*; D008297:Male; D011493:Protein Kinase C / Q000378:metabolism*; D021381:Protein Transport; D017966:Pyramidal Cells / Q000378:metabolism* / Q000502:physiology; D051381:Rats; D017207:Rats, Sprague-Dawley
chemical_list: D064428:Hyperpolarization-Activated Cyclic Nucleotide-Gated Channels; D011493:Protein Kinase C
references.citation: J Neurosci. 2007 Nov 21;27(47):13012-21
references.pmid: 18032674
references.citation: Neuron. 2007 Jun 21;54(6):933-47
references.pmid: 17582333
references.citation: Nat Neurosci. 2002 Nov;5(11):1185-93
references.pmid: 12389030
references.citation: Nat Neurosci. 1999 Sep;2(9):848
references.pmid: 10461231
references.citation: Int J Toxicol. 2007 Jul-Aug;26(4):279-88
references.pmid: 17661218
references.citation: J Neurosci. 1999 Jun 1;19(11):4337-48
references.pmid: 10341237
references.citation: Neuron. 2009 Jun 25;62(6):802-13
references.pmid: 19555649
references.citation: J Neurosci. 2007 Mar 14;27(11):2802-14
references.pmid: 17360902
references.citation: J Biol Chem. 2008 Oct 31;283(44):29912-9
references.pmid: 18768480
references.citation: J Neurosci. 2011 Oct 5;31(40):14291-5
references.pmid: 21976514
references.citation: Nat Commun. 2011;2:242
references.pmid: 21407208
references.citation: Ann Neurol. 2011 Sep;70(3):454-64
references.pmid: 21905079
references.citation: J Neurosci. 1999 Jan 15;19(2):674-83
references.pmid: 9880588
references.citation: J Physiol. 2007 Oct 15;584(Pt 2):437-50
references.pmid: 17702809
references.citation: Neuron. 2004 Feb 5;41(3):405-15
references.pmid: 14766179
references.citation: Nature. 1991 Oct 10;353(6344):558-60
references.pmid: 1656271
references.citation: J Physiol. 2007 Mar 1;579(Pt 2):431-43
references.pmid: 17185334
references.citation: J Neurosci. 2006 Jul 26;26(30):7995-8003
references.pmid: 16870744
references.citation: J Physiol. 1997 Aug 15;503 ( Pt 1):87-97
references.pmid: 9288677
references.citation: J Neurosci. 2008 Jan 9;28(2):376-84
references.pmid: 18184780
references.citation: J Neurosci. 2009 May 13;29(19):6250-65
references.pmid: 19439603
references.citation: Cell Physiol Biochem. 2013;31(4-5):532-41
references.pmid: 23571312
references.citation: Neuron. 2004 Oct 28;44(3):495-508
references.pmid: 15504329
references.citation: J Neurosci. 1998 May 15;18(10):3521-8
references.pmid: 9570783
references.citation: J Neurosci. 1998 Oct 1;18(19):7613-24
references.pmid: 9742133
references.citation: J Neurosci. 2008 Aug 6;28(32):7979-90
references.pmid: 18685023
references.citation: Pflugers Arch. 2004 Jan;447(4):392-400
references.pmid: 14634823
references.citation: J Neurosci. 2004 Nov 24;24(47):10750-62
references.pmid: 15564593
references.citation: J Biol Chem. 2004 Oct 15;279(42):43847-53
references.pmid: 15292205
references.citation: J Neurosci. 2008 Mar 5;28(10):2527-38
references.pmid: 18322097
references.citation: J Neurosci. 2010 May 12;30(19):6678-88
references.pmid: 20463230
references.citation: Neuroscience. 2006;139(4):1301-13
references.pmid: 16533575
references.citation: J Biol Chem. 2010 Dec 31;285(53):41795-805
references.pmid: 20940303
references.citation: Annu Rev Physiol. 2006;68:375-401
references.pmid: 16460277
references.citation: J Neurochem. 2008 Aug;106(4):1929-40
references.pmid: 18513371
references.citation: J Neurosci. 2003 Aug 20;23(20):7685-9
references.pmid: 12930808
references.citation: Physiol Rev. 2009 Jul;89(3):847-85
references.pmid: 19584315
references.citation: Neurobiol Dis. 2009 Mar;33(3):436-47
references.pmid: 19135151
references.citation: Cereb Cortex. 2010 Jul;20(7):1756-67
references.pmid: 19915095
references.citation: Epilepsia. 2006 Jun;47(6):1023-8
references.pmid: 16822248